Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein Sodium and Yellow 560 Microscope for Intracranial Lesions
NCT02028325Phase 4Terminated
- Sponsor
- Indiana University
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorescein sodium 10% injection in intracranial neoplasm, intracranial vascular lesion, sponsored by Indiana University. Started Dec 2013; status: terminated.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
intracranial neoplasmintracranial vascular lesion
Beyond the preview
Go deeper on NCT02028325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028325.